đź’¨ Abstract
Provectus Biopharmaceuticals Inc. (PVCT) reported a $1.1 million loss in the first quarter of 2025. Despite generating $278,600 in revenue, the company faced a loss of less than 1 cent per share. Notably, the article also references recent alerts: a broken air traffic control hotline between the Pentagon and Reagan National Airport since 2022, and Maryland's loss of its AAA bond rating.
Courtesy: wtop.com
Suggested
Wood drives in go-ahead run in 8th as Nationals end 7-game skid with 5-4 comeback win over Braves -
NFL teams have kids in mind with videos for schedule reveals, while Bears draw the most laughs -
Dodgers call up top prospect Dalton Rushing and cut loose veteran catcher Austin Barnes -
Russell-Rowe’s goal pushes Columbus Crew to 1-1 draw against feisty CF Montreal -
DC United’s Luis Barraza, NYCFC’s Matt Freese duel to scoreless draw -
The top photos of the day by AP’s photojournalists -
Stowers homers twice, Weathers strong in return to lead Marlins over Cubs 3-1 -
The Twins turned their season around. The Orioles are showing few signs of doing that -
Panthers rout the Maple Leafs 6-1 to take a 3-2 series lead -
Davis Martin helps the White Sox beat the slumping Reds 4-2 -